Reports for RIVASTIGMINE

Ingredient

RIVASTIGMINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ RIVASTIGMINE 1.5MG CAPSULE Resolved 2017-03-21 2017-05-17 3878
SANDOZ RIVASTIGMINE 1.5MG CAPSULE Resolved 2023-03-06 2023-04-05 186300
SANDOZ RIVASTIGMINE 1.5MG CAPSULE Resolved 2023-03-27 2023-04-05 188070
APO-RIVASTIGMINE 1.5MG CAPSULE Resolved 2017-09-04 2019-10-15 20900
APO-RIVASTIGMINE 1.5MG CAPSULE Resolved 2022-11-27 2023-03-09 175898
APO-RIVASTIGMINE 1.5MG CAPSULE Resolved 2023-07-21 2024-01-05 199518
APO-RIVASTIGMINE 1.5MG CAPSULE Actual shortage 2024-03-08 2024-03-22 221729
MYLAN-RIVASTIGMINE PATCH 10 18MG PATCH Resolved 2018-03-05 2018-04-05 41780
MYLAN-RIVASTIGMINE PATCH 10 18MG PATCH Resolved 2019-05-08 2019-07-30 83413
EXELON 2MG SOLUTION Resolved 2022-12-13 2023-11-06 178295

Showing 1 to 10 of 40

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-RIVASTIGMINE 1.5MG CAPSULE Discontinued 2017-06-21 2017-07-01 13562
MINT-RIVASTIGMINE 3MG CAPSULE Discontinued 2017-06-21 2017-07-01 13556
MINT-RIVASTIGMINE 4.5MG CAPSULE Discontinued 2017-06-21 2017-07-01 13565
MINT-RIVASTIGMINE 6MG CAPSULE Discontinued 2017-06-21 2017-07-01 13559

Showing 1 to 4 of 4